PL3042669T3 - Środek przeciwnowotworowy i środek wzmacniający efekt przeciwnowotworowy - Google Patents
Środek przeciwnowotworowy i środek wzmacniający efekt przeciwnowotworowyInfo
- Publication number
- PL3042669T3 PL3042669T3 PL14842538.2T PL14842538T PL3042669T3 PL 3042669 T3 PL3042669 T3 PL 3042669T3 PL 14842538 T PL14842538 T PL 14842538T PL 3042669 T3 PL3042669 T3 PL 3042669T3
- Authority
- PL
- Poland
- Prior art keywords
- cancer
- agent
- effect enhancing
- enhancing agent
- cancer effect
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Endocrinology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013184684 | 2013-09-06 | ||
| PCT/JP2014/073436 WO2015034032A1 (ja) | 2013-09-06 | 2014-09-05 | 抗腫瘍剤及び抗腫瘍効果増強剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3042669T3 true PL3042669T3 (pl) | 2023-06-26 |
Family
ID=52628493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14842538.2T PL3042669T3 (pl) | 2013-09-06 | 2014-09-05 | Środek przeciwnowotworowy i środek wzmacniający efekt przeciwnowotworowy |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US9943537B2 (pl) |
| EP (2) | EP4201424A1 (pl) |
| JP (2) | JP6425653B2 (pl) |
| KR (1) | KR101993963B1 (pl) |
| AU (1) | AU2014316030C1 (pl) |
| CY (2) | CY1126037T1 (pl) |
| DK (1) | DK3042669T3 (pl) |
| ES (1) | ES2946472T3 (pl) |
| FI (2) | FI3042669T3 (pl) |
| FR (1) | FR24C1005I1 (pl) |
| HR (1) | HRP20230523T1 (pl) |
| HU (2) | HUE062034T2 (pl) |
| LT (2) | LT3042669T (pl) |
| LU (1) | LUC00328I2 (pl) |
| NO (1) | NO2024005I1 (pl) |
| PL (1) | PL3042669T3 (pl) |
| PT (1) | PT3042669T (pl) |
| RS (1) | RS64243B1 (pl) |
| RU (1) | RU2682161C2 (pl) |
| SI (1) | SI3042669T1 (pl) |
| SM (1) | SMT202300167T1 (pl) |
| TW (1) | TWI641385B (pl) |
| UA (1) | UA121538C2 (pl) |
| WO (1) | WO2015034032A1 (pl) |
| ZA (1) | ZA201602258B (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014316030C1 (en) | 2013-09-06 | 2024-08-15 | Les Laboratoires Servier | Antitumor agent and antitumor effect enhancer |
| EP3693019A1 (en) | 2016-01-08 | 2020-08-12 | Taiho Pharmaceutical Co., Ltd. | Anti-tumor agent containing immunomodulator |
| EP3442534A1 (en) * | 2016-04-13 | 2019-02-20 | Boehringer Ingelheim International GmbH | Pharmaceutical combination of nintedanib, trifluridine and tipiracil for treating colorectal cancer |
| EP3646887A4 (en) * | 2017-06-30 | 2021-03-24 | Korea Advanced Institute of Science and Technology | CONJUGATE OF VEGF GRAB PROTEIN AND MEDICINAL PRODUCTS AND USES THEREOF |
| US12691115B2 (en) | 2019-05-14 | 2026-07-28 | Marshall University Research Corporation | Methods for treatment of obesity, atherosclerosis, and thrombosis |
| KR20220154986A (ko) | 2021-05-14 | 2022-11-22 | 윤상은 | 휴대용 마스크끈 절단기 |
| AR127893A1 (es) * | 2021-12-10 | 2024-03-06 | Servier Lab | Terapia del cáncer dirigida a egfr |
| TW202339786A (zh) | 2022-01-21 | 2023-10-16 | 日商中外製藥股份有限公司 | 癌症之治療或預防用醫藥 |
| WO2023204259A1 (ja) | 2022-04-20 | 2023-10-26 | 中外製薬株式会社 | がんの治療又は予防用医薬 |
| WO2024177036A1 (ja) * | 2023-02-20 | 2024-08-29 | 大鵬薬品工業株式会社 | Ftd・tpi配合剤、pd-1経路アンタゴニスト、及びvegf経路アンタゴニストの併用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3088757B2 (ja) | 1995-03-29 | 2000-09-18 | 大鵬薬品工業株式会社 | ウラシル誘導体並びにそれを含有する抗腫瘍効果増強剤及び抗腫瘍剤 |
| US7312243B1 (en) * | 2003-08-29 | 2007-12-25 | Jay Pravda | Materials and methods for treatment of gastrointestinal disorders |
| DK1849470T4 (en) | 2005-01-26 | 2024-04-02 | Taiho Pharmaceutical Co Ltd | Cancerlægemiddel, som indeholder alpha, alpha, alpha-trifluorthymidin og thymidin-phosphorylase-inhibitor |
| US7799783B2 (en) * | 2005-01-26 | 2010-09-21 | Taiho Pharmaceutical Co., Ltd. | Method of administrating an anticancer drug containing α, α, α-trifluorothymidine and thymidine phosphorylase inhibitor |
| US9616081B2 (en) | 2013-03-27 | 2017-04-11 | Taiho Pharmaceutical Co., Ltd. | Antitumor agent including low-dose irinotecan hydrochloride hydrate |
| UA114840C2 (uk) | 2013-03-27 | 2017-08-10 | Тайхо Фармасьютікал Ко., Лтд. | Протипухлинний агент, який включає гідрат гідрохлориду іринотекану |
| AU2014316030C1 (en) | 2013-09-06 | 2024-08-15 | Les Laboratoires Servier | Antitumor agent and antitumor effect enhancer |
-
2014
- 2014-09-05 AU AU2014316030A patent/AU2014316030C1/en active Active
- 2014-09-05 EP EP23154967.6A patent/EP4201424A1/en active Pending
- 2014-09-05 FI FIEP14842538.2T patent/FI3042669T3/fi active
- 2014-09-05 KR KR1020167005952A patent/KR101993963B1/ko active Active
- 2014-09-05 JP JP2015535524A patent/JP6425653B2/ja active Active
- 2014-09-05 LT LTEPPCT/JP2014/073436T patent/LT3042669T/lt unknown
- 2014-09-05 SI SI201432026T patent/SI3042669T1/sl unknown
- 2014-09-05 RS RS20230421A patent/RS64243B1/sr unknown
- 2014-09-05 TW TW103130882A patent/TWI641385B/zh active
- 2014-09-05 UA UAA201603578A patent/UA121538C2/uk unknown
- 2014-09-05 RU RU2016112421A patent/RU2682161C2/ru active
- 2014-09-05 PL PL14842538.2T patent/PL3042669T3/pl unknown
- 2014-09-05 US US14/916,878 patent/US9943537B2/en active Active
- 2014-09-05 HU HUE14842538A patent/HUE062034T2/hu unknown
- 2014-09-05 DK DK14842538.2T patent/DK3042669T3/da active
- 2014-09-05 EP EP14842538.2A patent/EP3042669B1/en active Active
- 2014-09-05 SM SM20230167T patent/SMT202300167T1/it unknown
- 2014-09-05 PT PT148425382T patent/PT3042669T/pt unknown
- 2014-09-05 HR HRP20230523TT patent/HRP20230523T1/hr unknown
- 2014-09-05 ES ES14842538T patent/ES2946472T3/es active Active
- 2014-09-05 WO PCT/JP2014/073436 patent/WO2015034032A1/ja not_active Ceased
-
2016
- 2016-04-05 ZA ZA2016/02258A patent/ZA201602258B/en unknown
-
2018
- 2018-01-15 JP JP2018004516A patent/JP6557744B2/ja active Active
-
2023
- 2023-06-07 CY CY20231100271T patent/CY1126037T1/el unknown
-
2024
- 2024-01-24 CY CY2024001C patent/CY2024001I1/el unknown
- 2024-01-24 FR FR24C1005C patent/FR24C1005I1/fr active Active
- 2024-01-24 LU LU00328C patent/LUC00328I2/fr unknown
- 2024-01-24 HU HUS2400001C patent/HUS2400001I1/hu unknown
- 2024-01-25 FI FIC20240002C patent/FIC20240002I1/fi unknown
- 2024-01-25 NO NO2024005C patent/NO2024005I1/no unknown
- 2024-01-26 LT LTPA2024502C patent/LTPA2024502I1/lt unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL269045A (en) | Aptamers and uses thereof | |
| DK3043784T3 (da) | Arylethere og anvendelser deraf | |
| BR302014001267S1 (pt) | Configuração aplicada em liquidificador | |
| DK3003039T3 (da) | Methyl/fluor-pyridinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser og fluor-pyrimidinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser | |
| EP2889350A4 (en) | ADHESIVE COMPOSITION | |
| DK3027750T3 (da) | Biokatalytisk sammensætning | |
| DK2962100T3 (da) | Tuberkulosebiomarkører og anvendelser deraf | |
| DK3077467T3 (da) | Sikkativsammensætning og anvendelse deraf | |
| EP2970569A4 (en) | PERSISTENT CARBENE AND COMPOSITIONS WITH IT | |
| BR302013005965S1 (pt) | Configuração aplicada em otomana | |
| PL3030519T3 (pl) | Trójpierścieniowe związki benzoksaborolu i ich zastosowania | |
| IL240248A0 (en) | Met-binding agents and uses thereof | |
| LT3042669T (lt) | Priešvėžinis agentas ir stipriklis su priešvėžiniu poveikiu | |
| DE112014002764A5 (de) | Schuh und Schuhset | |
| DK3071053T3 (da) | Præbiotisk sammensætning | |
| EP3012307A4 (en) | MIXED REFRIGERANT | |
| EP3041028A4 (en) | LAMINATE AND APPLICATION THEREOF | |
| BR302013005862S1 (pt) | Configuração aplicada em coador | |
| DK3068428T3 (da) | Annexin-ii-variant-sammensætninger og fremgangsmåder | |
| FR3007291B1 (fr) | Composition cicatrisante et utlisation | |
| HRP20181735T1 (hr) | Liposom za topikalnu primjenu i njegova uporaba | |
| EP2985312A4 (en) | AGGREGATE AND COMPOSITION | |
| BR302013001974S1 (pt) | Configuração aplicada em pnemático | |
| BR302013005268S1 (pt) | Configuração aplicada em muleta axilar | |
| BR302013004044S1 (pt) | Configuração aplicada em macação |